The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C.

Saved in:
Bibliographic Details
Title: The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C.
Authors: Shi Y; Merck & Co., Inc., Rahway, NJ, USA., Nolan KM; Merck & Co., Inc., Rahway, NJ, USA., Burton RL; SunFire Biotechnologies LLC, Birmingham, AL, USA., Shekar T; Merck & Co., Inc., Rahway, NJ, USA., Murphy RD; Merck & Co., Inc., Rahway, NJ, USA., Banniettis N; Merck & Co., Inc., Rahway, NJ, USA., Musey L; Merck & Co., Inc., Rahway, NJ, USA., Buchwald UK; Merck & Co., Inc., Rahway, NJ, USA.
Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Aug 01; Vol. 19 (2), pp. 2235238.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2164-554X
DOI:10.1080/21645515.2023.2235238